Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 28.00m |
Free float | 19.45m |
P/E (TTM) | -- |
Market cap | 9.59bn USD |
EPS (TTM) | -27.32 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
- Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
- Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
- Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
- Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
More ▼